Loperamide hydrochloride and Simethicone is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Bionpharma Inc.. The primary component is Loperamide Hydrochloride; Dimethicone.
| Product ID | 69452-210_ceb56ab8-4a61-6dee-e053-2995a90aab30 |
| NDC | 69452-210 |
| Product Type | Human Otc Drug |
| Proprietary Name | Loperamide hydrochloride and Simethicone |
| Generic Name | Loperamide Hydrochloride And Simethicone |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-12-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA213484 |
| Labeler Name | Bionpharma Inc. |
| Substance Name | LOPERAMIDE HYDROCHLORIDE; DIMETHICONE |
| Active Ingredient Strength | 2 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-12-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0363-9606 | Loperamide Hydrochloride and Simethicone | Loperamide Hydrochloride and Simethicone |
| 58602-815 | Loperamide Hydrochloride and Simethicone | Loperamide Hydrochloride and Simethicone |
| 58602-868 | Loperamide Hydrochloride and Simethicone | Loperamide Hydrochloride and Simethicone |
| 58602-869 | Loperamide Hydrochloride and Simethicone | Loperamide Hydrochloride and Simethicone |
| 69230-325 | Loperamide Hydrochloride and Simethicone | Loperamide Hydrochloride and Simethicone |
| 69452-210 | Loperamide hydrochloride and Simethicone | loperamide hydrochloride and simethicone |
| 69842-807 | loperamide hydrochloride and simethicone | loperamide hydrochloride, simethicone |
| 80136-384 | Loperamide Hydrochloride and Simethicone | Loperamide Hydrochloride and Simethicone |